首页 | 本学科首页   官方微博 | 高级检索  
     


Recent advances in mRNA-based vaccine for cancer therapy; bench to bedside
Authors:Hadeel Ahmed Kenoosh  Harikumar Pallathadka  Ahmed Hjazi  Aiman Mohammed Baqir Al-Dhalimy  Sajad Ali Zearah  Pallavi Ghildiyal  Zuhair I. Al-Mashhadani  Yasser Fakri Mustafa  Manar Mohammed Hizam  Ahmed Elawady
Affiliation:1. Department of Medical Laboratory Techniques, Al-Maarif University College, AL-Anbar, Iraq;2. Manipur International University, Imphal, Manipur, India;3. Department of Medical Laboratory, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia;4. Department of Nursing, Altoosi University College, Najaf, Iraq;5. Scientific Research Center, Al-Ayen University, Thi-Qar, Iraq;6. Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India;7. Anesthesia Techniques, Al-Nisour University College, Baghdad, Iraq;8. Department of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul, Iraq;9. College of Pharmacy, National University of Science and Technology, Dhi Qar, Iraq;10. College of Technical Engineering, The Islamic University, Najaf, Iraq

College of Technical Engineering, The Islamic University of Al Diwaniyah, Al Diwaniyah, Iraq

College of Technical Engineering, The Islamic University of Babylon, Babylon, Iraq

Abstract:The messenger RNA (mRNA) vaccines have progressed from a theoretical concept to a clinical reality over the last few decades. Compared to conventional vaccination methods, these vaccines have a number of benefits, such as substantial potency, rapid growth, inexpensive production, and safe administration. Nevertheless, their usefulness was restricted up to now due to worries about the erratic and ineffective circulation of mRNA in vivo. Thankfully, these worries have largely been allayed by recent technological developments, which have led to the creation of multiple mRNA vaccination platforms for cancer and viral infections. The mRNA vaccines have been demonstrated as a powerful alternative to traditional conventional vaccines because of their high potency, safety and efficacy, capacity for rapid clinical development, and potential for rapid, low-cost manufacturing. The paper will examine the present status of mRNA vaccine technology and suggest future paths for the advancement and application of this exciting vaccine platform as a common therapeutic choice.
Keywords:cancer  immunotherapy  mRNA vaccines  platforms
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号